hp802-247
Cell therapyexperimental
Clinical trial activity
9 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
8
Phase 3
3
Phase 4
0
Earliest trial started Feb 1, 2009 (NCT00852995)
Timeline
Indications
Mechanism of action
- KeratinocytesSupplementation
supplementation - keratinocytes
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hp-802-247
- hp802-247
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02154087 | Phase 2 | Jul 1, 2014 | Healthpoint, Smith & Nephew |
| NCT01853384 | Phase 3 | Nov 1, 2013 | Healthpoint, Smith & Nephew, University of Freiburg |
| NCT01737762 | Phase 3 | Nov 1, 2012 | Healthpoint, University of Miami, University of North Carolina at Chapel Hill |
| NCT01656889 | Phase 3 | Aug 1, 2012 | Healthpoint, Smith & Nephew |
| NCT01528306 | Phase 2 | Mar 1, 2012 | Healthpoint |
| NCT01359735 | Phase 2 | May 1, 2011 | Healthpoint |
| NCT01320605 | Phase 2 | Mar 1, 2011 | Atlantic Health System |
| NCT01190865 | Phase 1 | Sep 1, 2010 | Healthpoint, RCTS, Inc. |
| NCT00852995 | Phase 2 | Feb 1, 2009 | Healthpoint, University of Miami, University of North Carolina at Chapel Hill |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Healthpoint | For profit | 8 | 8 | 3 | 2009 |
| Smith & Nephew | For profit | 3 | 0 | 2 | 2012 |
| University of Miami | Academic/Hospital | 2 | 0 | 2 | 2009 |
| University of North Carolina at Chapel Hill | Academic/Hospital | 2 | 0 | 2 | 2009 |
| Atlantic Health System | Academic/Hospital | 1 | 1 | 1 | 2011 |
| RCTS, Inc. | For profit | 1 | 0 | 1 | 2010 |
| University of Freiburg | Academic/Hospital | 1 | 0 | 1 | 2013 |
7 organizations
Page 1 / 1